Fund Activity
Fund Portfolios
Latest stock portfolios of the world's best investors and hedge funds
Fund Trends
Stocks ranked by hedge fund and large institutional investor activity
Large Buys & Sells
Recent large buys and sells by hedge funds and large institutional investors
Analyst Outlook
Analyst Upside
Stocks ranked by analyst price target upside potential
Latest Price Targets
Latest analyst price targets & ratings by research analysts
Analysts
Research analysts, their latest ratings and performance metrics
Analyst Firms
Research analyst firms, their latest ratings and performance metrics
WSR Indexes
Fund Manager Index
Stock index based on fund manager activity updated each quarter
Search
Sign in
Sign up
OAM
NVLN
Oxford Asset Management’s
Novelion Therapeutics Inc. Common Shares
NVLN
Stock Holding History
Oxford Asset Management’s Portfolio
NVLN Stock Details
NVLN Fund Activity
Bought
Maintained
Sold
Quarter
Market Value
Status
Shares
Shares
Change %
Capital Flow
Portfolio Weight
Portfolio Position
2018
Q1
–
Sell
-42,808
Closed
-$138K
–
2024
2017
Q4
$138K
Buy
42,808
+14,211
+
50
%
+$45.8K
﹤0.01%
1502
2017
Q3
$201K
Sell
28,597
-22,572
-
44
%
-$159K
﹤0.01%
1423
2017
Q2
$472K
Sell
51,169
-64,141
-
56
%
-$592K
0.01%
1133
2017
Q1
$1.24M
Buy
+115,310
New
+$1.24M
0.03%
714
Sign up
Sign in
Fund Activity
Fund Portfolios
Latest stock portfolios of the world's best investors and hedge funds
Fund Trends
Stocks ranked by hedge fund and large institutional investor activity
Large Buys & Sells
Recent large buys and sells by hedge funds and large institutional investors
Analyst Outlook
Analyst Upside
Stocks ranked by analyst price target upside potential
Latest Price Targets
Latest analyst price targets & ratings by research analysts
Analysts
Research analysts, their latest ratings and performance metrics
Analyst Firms
Research analyst firms, their latest ratings and performance metrics
WSR Indexes
Fund Manager Index
Stock index based on fund manager activity updated each quarter
Theme
Close